Luteinizing Hormone–Releasing Hormone Agonist Triptorelin and Antagonist Cetrorelix Inhibit EGF-Induced c-fos Expression in Human Gynecological Cancers-Reference-Cited by-同舟云学术

Luteinizing Hormone–Releasing Hormone Agonist Triptorelin and Antagonist Cetrorelix Inhibit EGF-Induced c-fos Expression in Human Gynecological Cancers

Published:2000-08 Issue:2 Volume:78 Page:194-202
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Gründker Carsten,Völker Peter,Schulz Klaus-Dieter,Emons Günter

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference43 articles.

1. GnRH—Mechanisms of Action;Gründker,1999

2. The use of luteinizing hormone–releasing hormone agonists and antagonists in gynecological cancers;Emons;Hum Reprod,1994

3. Growth-inhibitory actions of analogues of luteinizing hormone releasing hormone on tumor cells;Emons;Trends Endocrinol Metab,1997

4. Presence of gonadotropin-releasing hormone and its messenger ribunucleic acid in human ovarian epithelial carcinoma;Ohno;Am J Obstet Gynecol,1993

5. Gonadotropin-releasing hormone (GnRH)-binding sites in human breast cancer cell lines and inhibitory effects of GnRH antagonists;Eidne;J Clin Endocrinol Metab,1987

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. GnRH-a-based fertility-sparing treatment of atypical endometrial hyperplasia (AEH) and early endometrial carcinoma (EC) patients: a multicenter, open-label, randomized designed clinical trial protocol;Trials;2024-09-02

2. The role of GnRH metabolite, GnRH-(1-5), in endometrial cancer;Frontiers in Endocrinology;2023-04-14

3. Lipoamino acid-modified GnRH analogs with receptor-mediated antiproliferative activity in prostate and ovarian cancer cells;Medicinal Chemistry Research;2021-06-16

4. Role of Gonadotropin-Releasing Hormone (GnRH) in Ovarian Cancer;Cells;2021-02-18

5. The Role of Gonadotropin-Releasing Hormone (GnRH) in Endometrial Cancer;Cells;2021-02-01